Annual Revenue
$12.06 M
-$693.00 K-5.43%
December 31, 2023
Summary
- As of February 8, 2025, AXDX annual revenue is $12.06 million, with the most recent change of -$693.00 thousand (-5.43%) on December 31, 2023.
- During the last 3 years, AXDX annual revenue has risen by +$894.00 thousand (+8.01%).
- AXDX annual revenue is now -5.43% below its all-time high of $12.75 million, reached on December 31, 2022.
Performance
AXDX Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$2.98 M
-$11.00 K-0.37%
September 30, 2024
Summary
- As of February 8, 2025, AXDX quarterly revenue is $2.98 million, with the most recent change of -$11.00 thousand (-0.37%) on September 30, 2024.
- Over the past year, AXDX quarterly revenue has stayed the same.
- AXDX quarterly revenue is now -22.95% below its all-time high of $3.86 million, reached on June 30, 2022.
Performance
AXDX Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$11.91 M
-$324.00 K-2.65%
September 30, 2024
Summary
- As of February 8, 2025, AXDX TTM revenue is $11.91 million, with the most recent change of -$324.00 thousand (-2.65%) on September 30, 2024.
- Over the past year, AXDX TTM revenue has stayed the same.
- AXDX TTM revenue is now -10.35% below its all-time high of $13.28 million, reached on June 30, 2022.
Performance
AXDX TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
AXDX Revenue Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -5.4% | 0.0% | 0.0% |
3 y3 years | +8.0% | 0.0% | 0.0% |
5 y5 years | +112.7% | 0.0% | 0.0% |
AXDX Revenue Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -5.4% | +2.4% | -22.9% | +5.8% | -10.3% | +2.1% |
5 y | 5-year | -5.4% | +29.7% | -22.9% | +40.0% | -10.3% | +28.1% |
alltime | all time | -5.4% | >+9999.0% | -22.9% | +582.8% | -10.3% | +2344.4% |
Accelerate Diagnostics Revenue History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $2.98 M(-0.4%) | $11.91 M(-2.6%) |
Jun 2024 | - | $2.99 M(+2.2%) | $12.23 M(+0.5%) |
Mar 2024 | - | $2.92 M(-3.5%) | $12.17 M(+0.9%) |
Dec 2023 | $12.06 M(-5.4%) | $3.03 M(-8.2%) | $12.06 M(+0.5%) |
Sep 2023 | - | $3.30 M(+12.9%) | $12.00 M(+2.9%) |
Jun 2023 | - | $2.92 M(+3.9%) | $11.66 M(-7.5%) |
Mar 2023 | - | $2.81 M(-5.4%) | $12.61 M(-1.1%) |
Dec 2022 | $12.75 M(+8.2%) | $2.97 M(+0.4%) | $12.75 M(-2.8%) |
Sep 2022 | - | $2.96 M(-23.3%) | $13.12 M(-1.2%) |
Jun 2022 | - | $3.86 M(+30.5%) | $13.28 M(+8.7%) |
Mar 2022 | - | $2.96 M(-11.5%) | $12.22 M(+3.7%) |
Dec 2021 | $11.78 M(+5.5%) | $3.34 M(+7.1%) | $11.78 M(+2.0%) |
Sep 2021 | - | $3.12 M(+11.6%) | $11.55 M(-3.9%) |
Jun 2021 | - | $2.80 M(+11.1%) | $12.01 M(+5.9%) |
Mar 2021 | - | $2.52 M(-19.0%) | $11.34 M(+1.6%) |
Dec 2020 | $11.16 M(+20.1%) | $3.11 M(-13.4%) | $11.16 M(-3.1%) |
Sep 2020 | - | $3.59 M(+68.8%) | $11.53 M(+12.9%) |
Jun 2020 | - | $2.13 M(-9.3%) | $10.21 M(+3.2%) |
Mar 2020 | - | $2.34 M(-32.5%) | $9.89 M(+6.4%) |
Dec 2019 | $9.30 M(+64.0%) | $3.47 M(+52.8%) | $9.30 M(+21.5%) |
Sep 2019 | - | $2.27 M(+25.7%) | $7.65 M(+13.6%) |
Jun 2019 | - | $1.81 M(+3.2%) | $6.73 M(+1.7%) |
Mar 2019 | - | $1.75 M(-4.0%) | $6.62 M(+16.7%) |
Dec 2018 | $5.67 M(+35.7%) | $1.82 M(+34.5%) | $5.67 M(-5.0%) |
Sep 2018 | - | $1.35 M(-19.9%) | $5.97 M(+9.7%) |
Jun 2018 | - | $1.69 M(+111.2%) | $5.44 M(+22.3%) |
Mar 2018 | - | $801.00 K(-62.2%) | $4.45 M(+6.5%) |
Dec 2017 | $4.18 M(+1598.0%) | $2.12 M(+155.9%) | $4.18 M(+99.2%) |
Sep 2017 | - | $828.00 K(+18.5%) | $2.10 M(+62.2%) |
Jun 2017 | - | $699.00 K(+31.9%) | $1.29 M(+110.8%) |
Mar 2017 | - | $530.00 K(+1259.0%) | $613.00 K(+149.2%) |
Dec 2016 | $246.00 K(+67.3%) | $39.00 K(+62.5%) | $246.00 K(+7.4%) |
Sep 2016 | - | $24.00 K(+20.0%) | $229.00 K(-22.9%) |
Jun 2016 | - | $20.00 K(-87.7%) | $297.00 K(+0.3%) |
Mar 2016 | - | $163.00 K(+640.9%) | $296.00 K(+101.4%) |
Dec 2015 | $147.00 K(+20.5%) | $22.00 K(-76.1%) | $147.00 K(-27.9%) |
Sep 2015 | - | $92.00 K(+384.2%) | $204.00 K(+59.4%) |
Jun 2015 | - | $19.00 K(+35.7%) | $128.00 K(+4.9%) |
Mar 2015 | - | $14.00 K(-82.3%) | $122.00 K(0.0%) |
Dec 2014 | $122.00 K(+154.2%) | $79.00 K(+393.8%) | $122.00 K(+121.8%) |
Sep 2014 | - | $16.00 K(+23.1%) | $55.00 K(+5.8%) |
Jun 2014 | - | $13.00 K(-7.1%) | $52.00 K(+13.0%) |
Mar 2014 | - | $14.00 K(+16.7%) | $46.00 K(-4.2%) |
Dec 2013 | $48.00 K(+166.7%) | $12.00 K(-7.7%) | $48.00 K(+33.3%) |
Sep 2013 | - | $13.00 K(+85.7%) | $36.00 K(+15.0%) |
Jun 2013 | - | $7000.00(-56.3%) | $31.30 K(-14.9%) |
Mar 2013 | - | $16.00 K(+92.8%) | $36.80 K(-13.0%) |
Dec 2012 | $18.00 K(-92.4%) | - | - |
Oct 2012 | - | $8300.00(-33.6%) | $42.30 K(-82.1%) |
Jul 2012 | $236.00 K(+16.8%) | $12.50 K(-5.3%) | $236.00 K(-27.3%) |
Apr 2012 | - | $13.20 K(+59.0%) | $324.50 K(-41.2%) |
Jan 2012 | - | $8300.00(-95.9%) | $551.60 K(-35.6%) |
Dec 2011 | $202.00 K(-82.0%) | - | - |
Oct 2011 | - | $202.00 K(+100.0%) | $856.90 K(-23.6%) |
Jul 2011 | $1.12 M(-50.1%) | $101.00 K(-58.0%) | $1.12 M(-64.7%) |
Apr 2011 | - | $240.30 K(-23.4%) | $3.18 M(+7.4%) |
Jan 2011 | - | $313.60 K(-32.8%) | $2.96 M(+9.8%) |
Oct 2010 | - | $466.40 K(-78.4%) | $2.70 M(+20.1%) |
Jul 2010 | $2.25 M | $2.16 M(>+9900.0%) | $2.25 M(+445.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Apr 2010 | - | $19.90 K(-60.2%) | $411.60 K(-38.6%) |
Jan 2010 | - | $50.00 K(+222.6%) | $670.20 K(-31.9%) |
Oct 2009 | - | $15.50 K(-95.2%) | $984.70 K(-22.5%) |
Jul 2009 | $1.27 M(+167.1%) | $326.20 K(+17.1%) | $1.27 M(+9.5%) |
Apr 2009 | - | $278.50 K(-23.6%) | $1.16 M(+23.1%) |
Jan 2009 | - | $364.50 K(+21.2%) | $941.60 K(+32.3%) |
Oct 2008 | - | $300.70 K(+39.5%) | $711.60 K(+49.7%) |
Jul 2008 | $475.50 K(+159.7%) | $215.50 K(+253.9%) | $475.50 K(+70.4%) |
Apr 2008 | - | $60.90 K(-54.7%) | $279.10 K(+15.9%) |
Jan 2008 | - | $134.50 K(+108.2%) | $240.90 K(+25.8%) |
Oct 2007 | - | $64.60 K(+238.2%) | $191.50 K(+4.6%) |
Jul 2007 | $183.10 K(-13.9%) | $19.10 K(-15.9%) | $183.10 K(-14.8%) |
Apr 2007 | - | $22.70 K(-73.3%) | $215.00 K(+1.4%) |
Jan 2007 | - | $85.10 K(+51.4%) | $212.10 K(+16.2%) |
Oct 2006 | - | $56.20 K(+10.2%) | $182.50 K(-14.2%) |
Jul 2006 | $212.70 K(-57.6%) | $51.00 K(+157.6%) | $212.70 K(-24.3%) |
Apr 2006 | - | $19.80 K(-64.3%) | $281.00 K(-26.3%) |
Jan 2006 | - | $55.50 K(-35.8%) | $381.30 K(-32.8%) |
Oct 2005 | - | $86.40 K(-27.6%) | $567.70 K(+12.9%) |
Jul 2005 | $502.10 K(+323.4%) | $119.30 K(-0.7%) | $503.00 K(+20.7%) |
Apr 2005 | - | $120.10 K(-50.4%) | $416.80 K(+29.0%) |
Jan 2005 | - | $241.90 K(+1014.7%) | $323.00 K(+173.5%) |
Oct 2004 | - | $21.70 K(-34.4%) | $118.10 K(-0.5%) |
Jul 2004 | $118.60 K(+124.6%) | $33.10 K(+25.9%) | $118.70 K(-122.4%) |
Apr 2004 | - | $26.30 K(-28.9%) | -$530.60 K(+89.2%) |
Jan 2004 | - | $37.00 K(+65.9%) | -$280.50 K(+142.9%) |
Oct 2003 | - | $22.30 K(-103.6%) | -$115.50 K(-319.2%) |
Jul 2003 | $52.80 K(-91.9%) | -$616.20 K(-322.9%) | $52.70 K(-94.3%) |
Apr 2003 | - | $276.40 K(+36.8%) | $922.90 K(+20.2%) |
Jan 2003 | - | $202.00 K(+6.0%) | $767.80 K(+2.0%) |
Oct 2002 | - | $190.50 K(-25.0%) | $752.50 K(+15.1%) |
Jul 2002 | $654.00 K(-23.6%) | $254.00 K(+109.4%) | $654.00 K(+33.3%) |
Apr 2002 | - | $121.30 K(-35.0%) | $490.80 K(-5.7%) |
Jan 2002 | - | $186.70 K(+102.9%) | $520.50 K(-12.0%) |
Oct 2001 | - | $92.00 K(+1.3%) | $591.40 K(-30.9%) |
Jul 2001 | $855.70 K(-45.4%) | $90.80 K(-39.9%) | $855.70 K(-22.7%) |
Apr 2001 | - | $151.00 K(-41.4%) | $1.11 M(-6.9%) |
Jan 2001 | - | $257.60 K(-27.7%) | $1.19 M(-15.9%) |
Oct 2000 | - | $356.30 K(+4.1%) | $1.41 M(-9.8%) |
Jul 2000 | $1.57 M(-45.9%) | $342.20 K(+47.1%) | $1.57 M(-29.5%) |
Apr 2000 | - | $232.60 K(-51.8%) | $2.22 M(-10.7%) |
Jan 2000 | - | $482.80 K(-5.3%) | $2.49 M(-8.2%) |
Oct 1999 | - | $509.80 K(-48.9%) | $2.71 M(-7.5%) |
Jul 1999 | $2.90 M(-60.8%) | $998.00 K(+99.6%) | $2.93 M(+20.5%) |
Apr 1999 | - | $500.00 K(-29.1%) | $2.43 M(-48.6%) |
Jan 1999 | - | $705.20 K(-3.2%) | $4.73 M(-28.6%) |
Oct 1998 | - | $728.50 K(+45.7%) | $6.63 M(-12.0%) |
Jul 1998 | $7.40 M(+196.0%) | $500.00 K(-82.1%) | $7.53 M(-5.0%) |
Apr 1998 | - | $2.80 M(+7.5%) | $7.93 M(+36.0%) |
Jan 1998 | - | $2.60 M(+59.8%) | $5.83 M(+65.3%) |
Oct 1997 | - | $1.63 M(+81.1%) | $3.53 M(+41.2%) |
Jul 1997 | $2.50 M(+19.0%) | $900.00 K(+28.6%) | $2.50 M(+4.2%) |
Apr 1997 | - | $700.00 K(+133.3%) | $2.40 M(+4.3%) |
Jan 1997 | - | $300.00 K(-50.0%) | $2.30 M(-4.2%) |
Oct 1996 | - | $600.00 K(-25.0%) | $2.40 M(+20.0%) |
Jul 1996 | $2.10 M | $800.00 K(+33.3%) | $2.00 M(+66.7%) |
Apr 1996 | - | $600.00 K(+50.0%) | $1.20 M(+100.0%) |
Jan 1996 | - | $400.00 K(+100.0%) | $600.00 K(+200.0%) |
Oct 1995 | - | $200.00 K | $200.00 K |
FAQ
- What is Accelerate Diagnostics annual revenue?
- What is the all time high annual revenue for Accelerate Diagnostics?
- What is Accelerate Diagnostics annual revenue year-on-year change?
- What is Accelerate Diagnostics quarterly revenue?
- What is the all time high quarterly revenue for Accelerate Diagnostics?
- What is Accelerate Diagnostics quarterly revenue year-on-year change?
- What is Accelerate Diagnostics TTM revenue?
- What is the all time high TTM revenue for Accelerate Diagnostics?
- What is Accelerate Diagnostics TTM revenue year-on-year change?
What is Accelerate Diagnostics annual revenue?
The current annual revenue of AXDX is $12.06 M
What is the all time high annual revenue for Accelerate Diagnostics?
Accelerate Diagnostics all-time high annual revenue is $12.75 M
What is Accelerate Diagnostics annual revenue year-on-year change?
Over the past year, AXDX annual revenue has changed by -$693.00 K (-5.43%)
What is Accelerate Diagnostics quarterly revenue?
The current quarterly revenue of AXDX is $2.98 M
What is the all time high quarterly revenue for Accelerate Diagnostics?
Accelerate Diagnostics all-time high quarterly revenue is $3.86 M
What is Accelerate Diagnostics quarterly revenue year-on-year change?
Over the past year, AXDX quarterly revenue has changed by $0.00 (0.00%)
What is Accelerate Diagnostics TTM revenue?
The current TTM revenue of AXDX is $11.91 M
What is the all time high TTM revenue for Accelerate Diagnostics?
Accelerate Diagnostics all-time high TTM revenue is $13.28 M
What is Accelerate Diagnostics TTM revenue year-on-year change?
Over the past year, AXDX TTM revenue has changed by $0.00 (0.00%)